David Dantzker

David Dantzker

Director/Board Member bei SURMODICS, INC.

Vermögen: 1 Mio $ am 31.03.2024

80 Jahre
Health Technology
Commercial Services
Consumer Services

Profil

David R.
Dantzker
founded Oligomerix, Inc. in 2006, where he is working as Director from 2011.
Dr. Dantzker also founded The Feinstein Institutes for Medical Research.
Dr. Dantzker also currently works at Origin Life Sciences, Inc., as Deputy Chairman & Chief Medical Officer from 2012, Surmodics, Inc., as Independent Director from 2011, ShiftWise, Inc., as Director, Shire Regenerative Medicine, Inc., as Director, Wheatley Partners LP, as Partner, Wheatley Medtech Partners LP, as Partner from 2001, and Wheatley Partners, as Partner from 2001.
Dr. Dantzker also formerly worked at Redox Pharmaceutical Corp., as Chief Executive Officer from 2000 to 2001, Long Island Jewish Medical Center, as President & Chief Executive Officer in 1997, American Board of Internal Medicine, as Chairman, Versamed Medical Systems LLC, as Chairman, CNS, Inc. (Delaware), as Director, Datascope Corp., as Director from 2008 to 2009, Agilix Corp., as Director, Valera Pharmaceuticals, Inc., as Director from 2003 to 2007, Comprehensive NeuroScience, Inc., as Director, Physicians for Human Rights, as Treasurer & Director, Woodbrook Group Holdings, Inc., as Director, Respiri Ltd., as Independent Non-Executive Director from 2012 to 2014, NovaRay Medical, Inc., as Director, VisionSense Ltd., as Director, Care Management Technologies, Inc., as Director, Comprehensive Clinical Development, Inc., as Director, the University of Michigan, as Professor-Medicine, Northwell Health, Inc., as President in 2000, Albert Einstein College of Medicine, Inc., as Professor-Medicine, and the University of Texas at Austin, as Professor-Medicine.
Dr. Dantzker received his undergraduate degree from New York University and doctorate degree from Jacobs School of Medicine & Biomedical Sciences.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
08.02.2024 39 124 ( 0,27% ) 1 Mio $ 31.03.2024

Aktive Positionen von David Dantzker

UnternehmenPositionBeginn
SURMODICS, INC. Director/Board Member 05.01.2011
Director/Board Member -
Corporate Officer/Principal 01.01.2001
Wheatley Partners LP Corporate Officer/Principal -
Chief Tech/Sci/R&D Officer 01.01.2012
Founder 01.01.2006
Private Equity Investor 01.01.2001
Director/Board Member -
Alle aktiven Positionen von David Dantzker

Ehemalige bekannte Positionen von David Dantzker

UnternehmenPositionEnde
RESPIRI LIMITED Director/Board Member 05.02.2014
░░░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von David Dantzker im Detail an

Ausbildung von David Dantzker

New York University Undergraduate Degree
Jacobs School of Medicine & Biomedical Sciences Doctorate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von David Dantzker im Detail an

Beziehungen

97

Beziehungen ersten Grades

31

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen3
SURMODICS, INC.

Health Technology

WOODBROOK GROUP HOLDINGS INC.

Finance

RESPIRI LIMITED

Health Technology

Private Unternehmen23

Retail Trade

Electronic Technology

Wheatley Partners LP

Finance

Health Technology

Finance

Commercial Services

Health Technology

Health Technology

Process Industries

Retail Trade

Health Technology

Commercial Services

Health Services

Health Services

Commercial Services

Finance

Commercial Services

Distribution Services

Commercial Services

Health Technology

Health Technology

Health Services

Commercial Services

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. David Dantzker